Trinity Biotech Announces Management Changes
John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial OfficerDUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) --...
Stay updated with breaking news from Eric Ribner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial OfficerDUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) --...
06.11.2023 - Company to host an investor conference call and webcast at 4:30pm EDTNEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) - Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi for mydriasis, preparing for regulatory ...
Nes-Ziona, Israel, Sept. 07, 2023 -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced that company management will present a corporate...
NEW YORK, Aug. 09, 2023 -- Eyenovia, Inc. , an ophthalmic technology company commercializing Mydcombi™ 1%/2.5% for mydriasis and developing the Optejet® device for use both in connection with...
Eyenovia is stepping up the capabilities of its facilities and taking advantage of the thriving innovation culture and expertise in Reno, Nevada, ...